Dennis Kai Ming Ip

Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study

Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J. Cowling et al. · The Lancet Infectious Diseases · 2022 · 75 citations · Full text

Vaccination, Covid-19 Pandemic, Hong Kong +9

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations

Guo‐Wang Lin, Caigang Xu, Kexin Chen et al. · The Lancet Oncology · 2019 · 68 citations

Genome-wide Association Study, Lymphoid Neoplasia, Disease Susceptibility +13

Strength and durability of antibody responses to BNT162b2 and CoronaVac

Benjamin J. Cowling, Irene Wong, Eunice Y. C. Shiu et al. · Vaccine · 2022 · 26 citations · Full text

Humoral Response, Immunology, Immunotherapy +19

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial

Nancy Leung, Samuel M. S. Cheng, Carolyn A. Cohen et al. · The Lancet Microbe · 2023 · 22 citations · Full text

Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine

Nancy Leung, Samuel M. S. Cheng, Mario Martín-Sánchez et al. · Clinical Infectious Diseases · 2022 · 18 citations · Full text